Annual Operating Expenses
$27.84 M
-$16.50 M-37.21%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual total operating expenses is $27.84 million, with the most recent change of -$16.50 million (-37.21%) on December 31, 2023.
- During the last 3 years, NRXP annual operating expenses has fallen by -$23.55 million (-45.83%).
- NRXP annual operating expenses is now -75.96% below its all-time high of $115.80 million, reached on December 31, 2021.
Performance
NRXP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$3.02 M
-$4.03 M-57.13%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly total operating expenses is $3.02 million, with the most recent change of -$4.03 million (-57.13%) on September 30, 2024.
- Over the past year, NRXP quarterly operating expenses has dropped by -$2.98 million (-49.62%).
- NRXP quarterly operating expenses is now -94.30% below its all-time high of $52.98 million, reached on December 31, 2021.
Performance
NRXP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NRXP Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.2% | -49.6% |
| 3 y3 years | -45.8% | -66.9% |
| 5 y5 years | -45.8% | -41.3% |
NRXP Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.0% | at low | -94.3% | at low |
| 5 y | 5-year | -76.0% | at low | -94.3% | +2983.6% |
| alltime | all time | -76.0% | at low | -94.3% | +2983.6% |
NRx Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.02 M(-57.1%) |
| Jun 2024 | - | $7.05 M(+17.5%) |
| Mar 2024 | - | $6.00 M(+36.1%) |
| Dec 2023 | $27.84 M(-37.2%) | $4.41 M(-24.1%) |
| Sep 2023 | - | $5.81 M(-29.1%) |
| Jun 2023 | - | $8.19 M(-13.2%) |
| Mar 2023 | - | $9.44 M(-4.6%) |
| Dec 2022 | $44.34 M | $9.89 M(+8.2%) |
| Sep 2022 | - | $9.14 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $9.60 M(-38.9%) |
| Mar 2022 | - | $15.71 M(-70.4%) |
| Dec 2021 | $115.80 M(+125.3%) | $52.98 M(+163.6%) |
| Sep 2021 | - | $20.10 M(+17.4%) |
| Jun 2021 | - | $17.12 M(-33.1%) |
| Mar 2021 | - | $25.61 M(-43.3%) |
| Dec 2020 | $51.39 M | $45.12 M(+776.3%) |
| Sep 2020 | - | $5.15 M(-5013.4%) |
| Jun 2020 | - | -$104.80 K |
FAQ
- What is NRx Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual operating expenses year-on-year change?
- What is NRx Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly operating expenses year-on-year change?
What is NRx Pharmaceuticals annual total operating expenses?
The current annual operating expenses of NRXP is $27.84 M
What is the all time high annual operating expenses for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual total operating expenses is $115.80 M
What is NRx Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, NRXP annual total operating expenses has changed by -$16.50 M (-37.21%)
What is NRx Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of NRXP is $3.02 M
What is the all time high quarterly operating expenses for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly total operating expenses is $52.98 M
What is NRx Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, NRXP quarterly total operating expenses has changed by -$2.98 M (-49.62%)